tiprankstipranks
Advertisement
Advertisement
Bausch + Lomb price target raised to $21 from $20 at H.C. Wainwright
PremiumThe FlyBausch + Lomb price target raised to $21 from $20 at H.C. Wainwright
1M ago
Bausch + Lomb Earnings Call Signals Growing Momentum
Premium
Company Announcements
Bausch + Lomb Earnings Call Signals Growing Momentum
1M ago
Bausch + Lomb price target raised to $23 from $21 at UBS
Premium
The Fly
Bausch + Lomb price target raised to $23 from $21 at UBS
1M ago
Bausch + Lomb launches EyeGility Inserter in U.S.
PremiumThe FlyBausch + Lomb launches EyeGility Inserter in U.S.
2M ago
Bausch + Lomb says Phase 2 study of BL1107 did not achieve primary endpoint
Premium
The Fly
Bausch + Lomb says Phase 2 study of BL1107 did not achieve primary endpoint
2M ago
Bausch + Lomb introduces Orphia AI-powered digital health platform
Premium
The Fly
Bausch + Lomb introduces Orphia AI-powered digital health platform
2M ago
Bausch + Lomb announces U.S. launch of PreserVision AREDS3
PremiumThe FlyBausch + Lomb announces U.S. launch of PreserVision AREDS3
4M ago
Bausch + Lomb launches Bi-Blade+ dual-port vitrectomy cutter in Europe
Premium
The Fly
Bausch + Lomb launches Bi-Blade+ dual-port vitrectomy cutter in Europe
4M ago
Bausch + Lomb Lifts Outlook After Margin-Heavy Quarter
Premium
Company Announcements
Bausch + Lomb Lifts Outlook After Margin-Heavy Quarter
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100